Relay Therapeutics, Inc. (RLAY)
16.62
-0.68
(-3.93%)
USD |
NASDAQ |
Oct 16, 12:46
Relay Therapeutics SG&A Expense (TTM) : 50.06M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.06M |
| March 31, 2026 | 49.00M |
| December 31, 2025 | 56.71M |
| September 30, 2025 | 61.40M |
| June 30, 2025 | 69.02M |
| March 31, 2025 | 75.53M |
| December 31, 2024 | 76.59M |
| September 30, 2024 | 76.45M |
| June 30, 2024 | 75.19M |
| March 31, 2024 | 75.17M |
| December 31, 2023 | 74.95M |
| September 30, 2023 | 74.56M |
| June 30, 2023 | 72.14M |
| March 31, 2023 | 69.49M |
| December 31, 2022 | 65.98M |
| Date | Value |
|---|---|
| September 30, 2022 | 65.15M |
| June 30, 2022 | 63.76M |
| March 31, 2022 | 60.72M |
| December 31, 2021 | 57.39M |
| September 30, 2021 | 57.38M |
| June 30, 2021 | 54.93M |
| March 31, 2021 | 46.56M |
| December 31, 2020 | 38.58M |
| September 30, 2020 | 26.47M |
| June 30, 2020 | 17.89M |
| March 31, 2020 | 15.34M |
| December 31, 2019 | 13.65M |
| September 30, 2019 | 10.23M |
| June 30, 2019 | 6.575M |
| March 31, 2019 | 3.067M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | 14.87M |
| TG Therapeutics, Inc. | 296.46M |
| Karyopharm Therapeutics, Inc. | 101.98M |
| Spyre Therapeutics, Inc. | 55.54M |
| Akebia Therapeutics, Inc. | 117.15M |